Merck Mercuriadis, founder of the influential catalog investment group Hipgnosis, is preparing to launch a re-vamped version ...

I've written this kind of article before, addressing whether it's smart to buy into the dividend-paying stocks in the S&P 500 ...

Explore the Hipgnosis founder's new venture, focused on music management and co-ownership for artists and managers.

Merck Mercuriadis, the architect behind Hipgnosis’s transformation of music rights into a mainstream asset class, is making a ...

SCHD's quality-focused approach sets it apart from other high-yield ETFs, as it focuses on financial strength and strong ...

Merck Mercuriadis aims to buy back the music rights he sold to the private equity firm while building a new investment ...